{"name":"Dr Salouti Eye Research Center","slug":"dr-salouti-eye-research-center","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Fluorometholone(FML)","genericName":"Fluorometholone(FML)","slug":"fluorometholone-fml","indication":"Inflammatory and allergic conditions of the eye (conjunctivitis, keratitis, iritis)","status":"marketed"},{"name":"Loteprednol (Lotemax)","genericName":"Loteprednol (Lotemax)","slug":"loteprednol-lotemax","indication":"Inflammation and pain following ocular surgery","status":"marketed"}]}],"pipeline":[{"name":"Fluorometholone(FML)","genericName":"Fluorometholone(FML)","slug":"fluorometholone-fml","phase":"marketed","mechanism":"Fluorometholone is a topical corticosteroid that suppresses inflammatory and immune responses in the eye by binding to glucocorticoid receptors.","indications":["Inflammatory and allergic conditions of the eye (conjunctivitis, keratitis, iritis)","Post-operative ocular inflammation","Steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe"],"catalyst":""},{"name":"Loteprednol (Lotemax)","genericName":"Loteprednol (Lotemax)","slug":"loteprednol-lotemax","phase":"marketed","mechanism":"Loteprednol is a corticosteroid that suppresses inflammatory and immune responses in the eye by binding to glucocorticoid receptors.","indications":["Inflammation and pain following ocular surgery","Seasonal allergic conjunctivitis","Uveitis","Dry eye disease"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}